Man vs. man-made marijuana: A case of drug-induced posterior reversible encephalopathy syndrome (PRES) due to K2, a synthetic cannabinoid (SCB)

• Main Authors: Priyanka Parajuli (Author), Manjari Rani Regmi (Author), Odalys Estefania Lara-Garcia (Author), Ismael Abu Limon (Author), Alan Deckard (Author)
• Format: Book
• Published: Greater Baltimore Medical Center, 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Synthetic Cannabinoids (SCB) are engineered chemical compounds that share a similar chemical structure with the active ingredient of marijuana, delta-9-tetrahydrocanabinol. Although the FDA has not approved the use of SCB without a prescription from a licensed health-care provider, the cost effectiv...